{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:36:30Z","timestamp":1790890590498,"version":"4.1.0"},"reference-count":21,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Ther Adv Neurol Disord"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:p>A 67-year-old male with Mitochondrial Encephalomyopathy with Lactic Acidosis and Stroke-Like Episodes (MELAS) who developed life-threatening Stevens-Johnson Syndrome (SJS) more than one month after initiating lamotrigine (LTG) for epilepsy management. Despite prompt LTG discontinuation and aggressive immunomodulatory therapy, the patient succumbed to severe infection and multiple organ failure. LTG-induced SJS is associated with multiple risk factors. The immune-activating microenvironment resulting from mitochondrial dysfunction may potentiate the risk of LTG-induced SJS. Lamotrigine should be used cautiously for epilepsy in high-risk patients, particularly those with mitochondrial encephalomyopathy (ME), and comprehensive evaluation is required to minimize severe hypersensitivity reactions.<\/jats:p>","DOI":"10.1177\/17562864261474798","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T08:31:30Z","timestamp":1785832290000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["Lamotrigine-induced Stevens-Johnson syndrome in the setting of mitochondrial encephalomyopathy: A case report"],"prefix":"10.1177","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-8852-4627","authenticated-orcid":false,"given":"Ye","family":"Tian","sequence":"first","affiliation":[{"name":"The Second Hospital of Hebei Medical University"},{"name":"Key Laboratory of Clinical Neurology (Hebei Medical University)"},{"name":"Neurological Laboratory of Hebei Province"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teng","family":"Chen","sequence":"additional","affiliation":[{"name":"The Second Hospital of Hebei Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwen","family":"Liu","sequence":"additional","affiliation":[{"name":"The Second Hospital of Hebei Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Wang","sequence":"additional","affiliation":[{"name":"The Second Hospital of Hebei Medical University"},{"name":"Key Laboratory of Clinical Neurology (Hebei Medical University)"},{"name":"Neurological Laboratory of Hebei Province"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9698-3485","authenticated-orcid":false,"given":"Lihong","family":"Zhang","sequence":"additional","affiliation":[{"name":"The Second Hospital of Hebei Medical University"},{"name":"Key Laboratory of Clinical Neurology (Hebei Medical University)"},{"name":"Neurological Laboratory of Hebei Province"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,8,4]]},"reference":[{"key":"e_1_3_7_2_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e31829bfe89"},{"key":"e_1_3_7_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.braindev.2013.01.006"},{"key":"e_1_3_7_4_2","doi-asserted-by":"publisher","DOI":"10.3390\/biom14121524"},{"key":"e_1_3_7_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2015.06.004"},{"key":"e_1_3_7_6_2","doi-asserted-by":"publisher","DOI":"10.1590\/abd1806-4841.20175070"},{"key":"e_1_3_7_7_2","first-page":"57","article-title":"Recent Updates in the Treatment of Erythema Multiforme","volume":"57","author":"Soares A","year":"2021","unstructured":"Soares A, Sokumbi O. Recent Updates in the Treatment of Erythema Multiforme. Medicina (Kaunas) 2021; 57: 57. https:\/\/doi.org\/10.3390\/medicina57090921","journal-title":"Medicina (Kaunas)"},{"key":"e_1_3_7_8_2","doi-asserted-by":"publisher","DOI":"10.51821\/84.3.019"},{"issue":"124","key":"e_1_3_7_9_2","article-title":"Mitochondrial dysfunction: mechanisms and advances in therapy","volume":"9","author":"Zong Y","year":"2024","unstructured":"Zong Y, Li H, Liao P. Mitochondrial dysfunction: mechanisms and advances in therapy. Signal Transduct Target Ther 2024; 9(124): https:\/\/doi.org\/10.1038\/s41392-024-01839-8","journal-title":"Signal Transduct Target Ther"},{"key":"e_1_3_7_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mito.2017.10.006"},{"key":"e_1_3_7_11_2","doi-asserted-by":"publisher","DOI":"10.64719\/pb.4398"},{"key":"e_1_3_7_12_2","doi-asserted-by":"publisher","DOI":"10.2332\/allergolint.55.17"},{"issue":"5371854","key":"e_1_3_7_13_2","article-title":"Lamotrigine-Valproic Acid Interaction Leading to Stevens-Johnson Syndrome","volume":"2018","author":"Vazquez M","year":"2018","unstructured":"Vazquez M, Maldonado C, Guevara N, et al. Lamotrigine-Valproic Acid Interaction Leading to Stevens-Johnson Syndrome. Case Rep Med 2018; 2018(5371854): https:\/\/doi.org\/10.1155\/2018\/5371854","journal-title":"Case Rep Med"},{"key":"e_1_3_7_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharep.2014.11.009"},{"key":"e_1_3_7_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2018.06.024"},{"key":"e_1_3_7_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10863-010-9317-4"},{"key":"e_1_3_7_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurot.2023.10.002"},{"key":"e_1_3_7_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.spen.2013.10.001"},{"key":"e_1_3_7_19_2","doi-asserted-by":"publisher","DOI":"10.2174\/157015912804499447"},{"key":"e_1_3_7_20_2","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2012.5149"},{"issue":"101759","key":"e_1_3_7_21_2","first-page":"2020\/10\/22","article-title":"Innate-adaptive immunity interplay and redox regulation in immune response","volume":"37","author":"Sun L","year":"2020","unstructured":"Sun L, Wang X, Saredy J, et al. Innate-adaptive immunity interplay and redox regulation in immune response. Redox Biol 2020; 37(101759): 2020\/10\/22. https:\/\/doi.org\/10.1016\/j.redox.2020.101759","journal-title":"Redox Biol"},{"key":"e_1_3_7_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1980"}],"container-title":["Therapeutic Advances in Neurological Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/17562864261474798","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/17562864261474798","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/17562864261474798","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T13:18:11Z","timestamp":1786022291000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/17562864261474798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":21,"alternative-id":["10.1177\/17562864261474798"],"URL":"https:\/\/doi.org\/10.1177\/17562864261474798","relation":{},"ISSN":["1756-2864","1756-2864"],"issn-type":[{"value":"1756-2864","type":"print"},{"value":"1756-2864","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8]]},"article-number":"17562864261474798"}}